![Quiver Logo](/static/img/logo-icon.png)
![AXSM logo](https://quiver-logos.s3.us-east-2.amazonaws.com/axsm.png)
Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AXSM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of AXSM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AXSM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to AXSM
Recent picks made for AXSM stock on CNBC
ETFs with the largest estimated holdings in AXSM
Flights by private jets registered to AXSM
![Quiver Logo](/static/img/logo-icon.png)